21 days ago
ALMS
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 3%
#127 out of 5184 analysts
Average Return
+29.45%
Win Rate
62%87 out of 141
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +673.81% | $3.36 | $26.00 | 2025-06-09 - 2026-01-27 | Strong Buy |
Phathom Pharmaceuticals IncPHAT | +415.58% | $2.76 | $14.23 | 2025-05-01 - 2026-01-27 | Strong Buy |
Zura Bio LtdZURA | +381.65% | $1.34 | $6.43 | 2025-03-25 - 2026-01-27 | Strong Buy |
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-18 - 2023-09-25 | Strong Buy |
Anaptysbio IncANAB | +204.79% | $15.02 | $45.78 | 2024-12-11 - 2025-12-11 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
a month ago
DBVT
2 months ago
PRAX
3 months ago
IFRX
3 months ago
PRAX
4 months ago
ABVX
4 months ago
ACET
4 months ago
ROIV
6 months ago
NBIX
6 months ago
ARGX
6 months ago
ABVX
a year ago
ARGX
a year ago
SYRE
2 years ago
CLDX
2 years ago
AXSM
2 years ago
LBPH
2 years ago
ARGX
3 years ago
ARGX
3 years ago
LRMR
3 years ago
RXDX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alumis IncALMS | 3 | Strong Buy | $32.00 | +23.08% | Maintains | 21 days ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $15.00 | +250.47% | Initiates Coverage On | a month ago |
Dbv Technologies SaDBVT | 2 | Strong Buy | $51.00 | +108.67% | Maintains | a month ago |
Praxis Precision Medicines IncPRAX | 4 | Strong Buy | $760.00 | +141.46% | Maintains | 2 months ago |
Inflarx NvIFRX | 4 | Strong Buy | $22.00 | +2,175.08% | Maintains | 3 months ago |
Anaptysbio IncANAB | 10 | Strong Buy | $100.00 | +101.09% | Maintains | 3 months ago |
Axsome Therapeutics IncAXSM | 8 | Strong Buy | $205.00 | +9.03% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $865.00 | +12.16% | Maintains | 3 months ago |
Neumora Therapeutics IncNMRA | 2 | Strong Buy | $14.00 | +557.28% | Upgrades | 3 months ago |
Rapt Therapeutics IncRAPT | 3 | Strong Buy | $70.00 | +21.51% | Initiates Coverage On | 3 months ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $60.00 | +71.92% | Initiates Coverage On | 3 months ago |
Abivax SaABVX | 3 | Strong Buy | $150.00 | +26.17% | Maintains | 4 months ago |
Adicet Bio IncACET | 3 | Strong Buy | $128.00 | +1,398.83% | Maintains | 4 months ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $20.00 | +23.08% | Maintains | 4 months ago |
Argenx SeARGX | 11 | Strong Buy | $1,070.00 | +23.78% | Reiterates | 4 months ago |
Roivant Sciences LtdROIV | 3 | Strong Buy | $21.00 | -6.79% | Maintains | 4 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 5 months ago |
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $100.00 | +98.77% | Maintains | 5 months ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | +111.09% | Initiates Coverage On | 5 months ago |
Cabaletta Bio IncCABA | 6 | Strong Buy | $15.00 | +396.69% | Maintains | 6 months ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $175.00 | +30.70% | Maintains | 6 months ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | +608.45% | Reiterates | 7 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | +78.90% | Maintains | 9 months ago |
Phathom Pharmaceuticals IncPHAT | 3 | Strong Buy | $12.00 | -15.67% | Maintains | 9 months ago |
Zura Bio LtdZURA | 2 | Strong Buy | $15.00 | +133.28% | Reiterates | 10 months ago |
Zenas Biopharma IncZBIO | 2 | Strong Buy | $45.00 | +124.22% | Reiterates | a year ago |
Immunovant IncIMVT | 4 | Strong Buy | $44.00 | +64.00% | Maintains | a year ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | N/A | Upgrades | a year ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 3 years ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $736.00 | N/A | Maintains | 3 years ago |
Biogen IncBIIB | 3 | Strong Buy | $350.00 | N/A | Upgrades | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 3 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Climb Bio IncCLYM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 8 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.